Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bicyclol for chronic hepatitis B.

T Wu1, H Roger, L Xie

  • 1West China Hospital, Sichuan University, Chinese Cochrane Centre, Chinese EBM Centre, No. 37, Guo Xue Xiang, Chengdu, Sichuan, China. txwutx@hotmail.com

The Cochrane Database of Systematic Reviews
|October 21, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Safety and efficacy analysis of a varicose vein sealant kit in the treatment of great saphenous vein dysfunction].

Zhonghua yi xue za zhi·2024
Same author

[Investigation and analysis of airborne allergenic pollen in 4 districts and 5 counties of Hohhot City].

Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]·2023
Same author

Association between Frailty Assessed Using Two Electronic Medical Record-Based Frailty Assessment Tools and Long-Term Adverse Prognosis in Older Critically Ill Survivors.

The journal of nutrition, health & aging·2023
Same author

[Investigation of contamination of SARS-CoV-2 in imported frozen seafood from a foreign cargo ship and risk factors for infection in stevedores in Qingdao].

Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi·2021
Same author

[A case presentation of an overlapping syndrome concurrent with Epstein-Barr virus infection and drug-induced liver injury].

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology·2020
Same author

Transsphenoidal Optic Canal Decompression for Traumatic Optic Neuropathy Assisted by a Computed Tomography Image Postprocessing Technique.

Journal of ophthalmology·2020
Same journal

Interventions to prevent or cease electronic cigarette use in children and adolescents.

The Cochrane database of systematic reviews·2026
Same journal

Drugs to improve anaemia, quality of life, and physical function in people with myelodysplastic syndromes (MDS).

The Cochrane database of systematic reviews·2026
Same journal

Interventions for smoking cessation in inpatient psychiatry settings.

The Cochrane database of systematic reviews·2026
Same journal

Mechanical thromboprophylaxis for preventing intradialytic hypotension in people undergoing maintenance haemodialysis.

The Cochrane database of systematic reviews·2026
Same journal

Prognostic models for predicting intensive care unit admission or mortality in critically ill adults not yet been admitted to the intensive care unit.

The Cochrane database of systematic reviews·2026
Same journal

Views and experiences of weight management for people living with mobility‑limiting conditions, intellectual disabilities or severe mental illness: a qualitative evidence synthesis.

The Cochrane database of systematic reviews·2026
See all related articles

This review found insufficient evidence to support bicyclol for chronic hepatitis B. More large, long-term trials are needed to determine the benefits and harms of this anti-hepatitis drug.

Area of Science:

  • Hepatology
  • Pharmacology
  • Evidence-based medicine

Background:

  • Bicyclol is a synthetic anti-hepatitis drug used in China for chronic hepatitis B.
  • Systematic reviews on bicyclol therapy have not been previously conducted.

Purpose of the Study:

  • To evaluate the benefits and harms of bicyclol in patients with chronic hepatitis B.

Main Methods:

  • Comprehensive literature search across multiple databases (MEDLINE, EMBASE, Cochrane Library, etc.) up to July 2005.
  • Included randomized clinical trials regardless of blinding, publication status, or language.
  • Primary outcomes included mortality and liver-related morbidity; secondary outcomes were viral response and liver histology.

Main Results:

Related Experiment Videos

  • One small, three-month randomized trial comparing bicyclol to bifendate was identified.
  • No significant evidence showed bicyclol superiority for HBeAg loss, HBeAg seroconversion, HBV DNA loss, or normalized liver enzymes.

    • Conclusions:

    • The current evidence is insufficient to support or refute the use of bicyclol for chronic hepatitis B.
    • Large, long-term, randomized, double-blind trials are required to establish efficacy and safety.
    • Bicyclol is recommended only within the context of randomized trials.